Viromed Medical AG (DU:Q11) — Market Cap & Net Worth
Market Cap & Net Worth: Viromed Medical AG (Q11)
Viromed Medical AG (DU:Q11) has a market capitalization of $449.86 Million (€384.79 Million) as of August 4, 2026. Listed on the DU stock exchange, this Germany-based company holds position #12647 globally and #1360 in its home market, demonstrating a -1.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viromed Medical AG's stock price €7.40 by its total outstanding shares 454107008 (454.11 Million). See how much does Viromed Medical AG reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Viromed Medical AG Market Cap History: 2023 to 2026
Viromed Medical AG's market capitalization history from 2023 to 2026. Data shows change from $2.12 Billion to $3.93 Billion (-0.78% CAGR).
Viromed Medical AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Viromed Medical AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of Q11 by Market Capitalization
Companies near Viromed Medical AG in the global market cap rankings as of August 4, 2026.
Key companies related to Viromed Medical AG by market ranking:
- Newmont Goldcorp Corp (NYSE:NEM): Ranked #235 globally with a market cap of $104.07 Billion USD.
- Newmont Corporation (AU:NEM): Ranked #246 globally with a market cap of $101.69 Billion USD ( AU$143.71 Billion AUD).
- Zijin Mining Group Co Ltd Class A (SHG:601899): Ranked #259 globally with a market cap of $98.12 Billion USD ( CN¥670.56 Billion CNY).
- Agnico Eagle Mines Limited (TO:AEM): Ranked #374 globally with a market cap of $73.62 Billion USD ( CA$101.77 Billion CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #235 | Newmont Goldcorp Corp | NYSE:NEM | $104.07 Billion | $95.37 |
| #246 | Newmont Corporation | AU:NEM | $101.69 Billion | AU$134.62 |
| #259 | Zijin Mining Group Co Ltd Class A | SHG:601899 | $98.12 Billion | CN¥32.55 |
| #374 | Agnico Eagle Mines Limited | TO:AEM | $73.62 Billion | CA$203.52 |
Viromed Medical AG Historical Marketcap From 2023 to 2026
Between 2023 and today, Viromed Medical AG's market cap moved from $2.12 Billion to $ 3.93 Billion, with a yearly change of -0.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.93 Billion | +104.42% |
| 2025 | €1.92 Billion | +44.80% |
| 2024 | €1.33 Billion | -37.50% |
| 2023 | €2.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Viromed Medical AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $449.86 Million USD |
| MoneyControl | $449.86 Million USD |
| MarketWatch | $449.86 Million USD |
| marketcap.company | $449.86 Million USD |
| Reuters | $449.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Viromed Medical AG
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.